Notice 28 Apr 2025 controlled substances, import permits, regulatory compliance, business operations, drug enforcement

🚨Lipomed's Application for Importing Controlled Substances Notice

Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Apr 2025 regulation, drug enforcement, compliance, specgx llc, controlled substances, pharmaceuticals

💊DEA Notice

SpecGx LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Apr 2025 pharmacy regulations, drug enforcement, controlled substances, business compliance, dea, pennsylvania

💊DEA Revokes Registrations of Multiple Pennsylvania Pharmacies

The DEA issued an Order to Show Cause and Immediate Suspension of Registrations to several pharmacies, alleging violations related to the dispensing and recordkeeping of controlled substances. The findings indicate significant discrepancies in record management, endangering public health, and leading to potential revocation of their registration for the sale of drugs.

Learn More
Notice 23 Apr 2025 regulation, business consequences, pharmaceuticals, healthcare, drug enforcement, compliance, dea, controlled substances

⚖️DEA Revocation Decision Impacting De Novo Services, LLC

The Drug Enforcement Administration (DEA) has issued an order revoking the registration of De Novo Services, LLC due to substantial violations in managing controlled substances and maintaining proper recordkeeping. The decision underscores the stringent compliance requirements enforced by federal regulations to protect public health and safety, highlighting the consequences of non-adherence.

Learn More
Notice 22 Apr 2025 registration, healthcare, regulations, dea, business risk, compliance, drug enforcement

⚖️DEA Decision on Svetlana Burtman

The Department of Justice's ruling on Svetlana Burtman highlights numerous violations of the Controlled Substances Act, including operating an unregistered practice and failing to maintain adequate records. This decision underscores the rigorous compliance requirements for healthcare providers regarding controlled substances. The ramifications may extend beyond individual practitioners, influencing broader regulatory practices in the healthcare industry.

Learn More
Notice 21 Apr 2025 drug enforcement, medicine, healthcare, compliance, legal, tennessee, dea

⚖️DEA Revokes Registration of Dr. John Stanton Due to Legal Issues

The Drug Enforcement Administration (DEA) issued an Order to Show Cause against Dr. John Stanton, proposing to revoke his registration due to the loss of state medical authority. The decision directly relates to his felony conviction and the revocation of his medical license in Tennessee, thereby blocking his ability to dispense controlled substances.

Learn More
Notice 18 Apr 2025 controlled substances, pharmaceutical industry, drug enforcement, regulatory compliance, manufacturing

💊Patheon API Services Inc. Applies for Controlled Substances Registration

Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 controlled substances, restek corporation, bulk manufacturing, drug enforcement, regulatory compliance, pharmaceuticals

⚖️Restek Corporation's Bulk Manufacturer Application for Controlled Substances

Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 united states, controlled substances, compliance, drug enforcement, pharmaceuticals, manufacturing, business registration

💊DEA Notice

Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 controlled substances, clinical trials, compliance, drug enforcement, dea, myonex llc, pharmaceuticals

💊Notice of Application for Controlled Substances by Myonex LLC

Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More